Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JEREMY M COX

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI
1972831618
CMS profile
89182
Location
RIVERSIDE, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2019 · Entire year

$1,236.61

33 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2019 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,084.51 32
Travel and Lodging $152.10 1

By paying entity

PY2019 · entire year · sorted by reported total

Page 1 of 1; records 1–33 of 33 matching records. This page contains 33 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JEREMY M COX

NPI 1972831618 · CMS profile ID 89182

Allopathic & Osteopathic Physicians / Internal Medicine / Cardiovascular Disease

RIVERSIDE, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–33 of 33 matching records. This page contains 33 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1972831618?year=2019&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JEREMY M COX, NPI 1972831618, CMS profile ID 89182. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–33 of 33 matching records. This page contains 33 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1972831618?year=2019&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
APA 7
IndustryPayments. (2026). JEREMY M COX, NPI 1972831618, CMS profile ID 89182. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–33 of 33 matching records. This page contains 33 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1972831618?year=2019&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
Bluebook
JEREMY M COX, NPI 1972831618, CMS profile ID 89182, IndustryPayments, General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–33 of 33 matching records. This page contains 33 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e. https://industrypayments.org/provider/npi-1972831618?year=2019&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2019 · Physicians and non-physician practitioners · CMS publication 2026-06-30

33 matching records · $1,236.61 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 33 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–33 of 33.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Novartis Pharmaceuticals Corporation $11.9612/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658982101 CMS
Novartis Pharmaceuticals Corporation $7.2111/25/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658982107 CMS
Janssen Pharmaceuticals, Inc $11.3711/18/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658467535 CMS
Novartis Pharmaceuticals Corporation $18.7611/07/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658982103 CMS
Medtronic Vascular, Inc. $11.2311/01/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 677098955 CMS
PFIZER INC. $95.3210/08/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673316979 CMS
Amgen Inc. $5.7610/04/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662500359 CMS
Novartis Pharmaceuticals Corporation $0.9310/02/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658982097 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $49.1408/28/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 625116475 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $49.1408/28/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 625116477 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $21.3308/09/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 700264167 CMS
Novartis Pharmaceuticals Corporation $12.5108/05/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658982089 CMS
Novartis Pharmaceuticals Corporation $17.3407/22/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658982085 CMS
Novartis Pharmaceuticals Corporation $125.0007/16/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658982093 CMS
Novartis Pharmaceuticals Corporation $7.0006/07/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658982067 CMS
Alnylam Pharmaceuticals Inc. $124.9905/28/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 701568983 CMS
SANOFI-AVENTIS U.S. LLC $22.5005/20/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694107501 CMS
PFIZER INC. $20.0004/04/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673751129 CMS
Novartis Pharmaceuticals Corporation $4.5303/29/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658982077 CMS
Novartis Pharmaceuticals Corporation $7.4103/01/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658982073 CMS
Medtronic Vascular, Inc. $42.3402/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 676892099 CMS
SANOFI-AVENTIS U.S. LLC $24.3702/06/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 693925597 CMS
PFIZER INC. $5.1002/05/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673295791 CMS
PFIZER INC. $4.2001/30/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673295415 CMS
Amgen Inc. $46.2301/26/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 663334539 CMS
Amgen Inc. $23.1101/26/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 663334543 CMS
Amgen Inc. $46.2301/26/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 663334545 CMS
Amgen Inc. $23.1101/26/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 663334549 CMS
Amgen Inc. $152.1001/25/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 663334535 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $19.3901/25/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 700264169 CMS
Medtronic Vascular, Inc. $33.3301/24/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 676892061 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $68.6701/23/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 625116473 CMS
Novartis Pharmaceuticals Corporation $125.0001/15/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658982081 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,236.61 33
PY2020 $212.17 5
PY2021 $47.87 3
PY2022 $539.01 32
PY2023 $462.93 21
PY2024 $289.60 16
PY2025 $360.31 17

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2022 Principal investigator $37,178.60 24
PY2021 Principal investigator $69,598.51 32
PY2020 Principal investigator $153,961.23 91
PY2019 Principal investigator $248,597.19 151

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

151 records in PY2019

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $6,099.47 12/31/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 704731377
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $6,099.47 12/31/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 704731379
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $12,198.93 12/31/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 704731383
Principal investigator 1 Boehringer Ingelheim International GmbH $1,379.00 12/13/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703927249
Principal investigator 1 Boehringer Ingelheim International GmbH $1,379.00 12/13/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703927251
Principal investigator 1 Boehringer Ingelheim International GmbH $1,048.00 12/13/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703927253
Principal investigator 1 Boehringer Ingelheim International GmbH $1,535.00 12/03/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703924357
Principal investigator 1 Boehringer Ingelheim International GmbH $1,535.00 12/03/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703924359
Principal investigator 1 Boehringer Ingelheim International GmbH $1,129.00 12/03/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703924361
Principal investigator 1 Boehringer Ingelheim International GmbH $1,048.00 12/03/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703924363
Principal investigator 1 Boehringer Ingelheim International GmbH $1,379.00 11/22/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703923177
Principal investigator 1 Boehringer Ingelheim International GmbH $1,379.00 11/22/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703923297
Principal investigator 1 Boehringer Ingelheim International GmbH $1,535.00 11/22/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703923653
Principal investigator 1 Boehringer Ingelheim International GmbH $1,535.00 11/22/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703923655
Principal investigator 1 Boehringer Ingelheim International GmbH $1,535.00 11/22/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703923657
Principal investigator 1 Boehringer Ingelheim International GmbH $1,535.00 11/22/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703923659
Principal investigator 1 Boehringer Ingelheim International GmbH $1,535.00 11/22/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703923765
Principal investigator 1 Boehringer Ingelheim International GmbH $1,535.00 11/22/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703924223
Principal investigator 1 Boehringer Ingelheim International GmbH $180.91 11/04/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703925293
Principal investigator 1 Boehringer Ingelheim International GmbH $5.08 11/04/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703925301
Principal investigator 1 Boehringer Ingelheim International GmbH $2.50 11/04/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703925307
Principal investigator 1 Boehringer Ingelheim International GmbH $51.76 11/04/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703927497
Principal investigator 1 Boehringer Ingelheim International GmbH $51.76 11/04/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703927499
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $3,049.73 10/31/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 704731371
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $3,558.02 10/31/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 704731373
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $2,541.44 10/31/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 704731375
Principal investigator 1 PFIZER INC. $657.52 10/23/2019 Non-covered Recipient Entity
COVIGILANT RESEARCH LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 671670005
Principal investigator 1 Boehringer Ingelheim International GmbH $1,048.00 10/15/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703922287
Principal investigator 1 Boehringer Ingelheim International GmbH $1,129.00 10/02/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703922423
Principal investigator 1 Boehringer Ingelheim International GmbH $138.00 10/02/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703922425
Principal investigator 1 Amgen Inc. $64,087.00 09/23/2019 Non-covered Recipient Entity
COVIGILANT RESEARCH, LLC
VESALIUS-CV No dispute reported 06/30/2026 675784851
Principal investigator 1 PFIZER INC. $390.00 09/18/2019 Non-covered Recipient Entity
COVIGILANT RESEARCH LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 671669323
Principal investigator 1 PFIZER INC. $29.50 09/18/2019 Non-covered Recipient Entity
COVIGILANT RESEARCH LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 671671019
Principal investigator 1 PFIZER INC. $100.00 09/18/2019 Non-covered Recipient Entity
COVIGILANT RESEARCH LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 671673009
Principal investigator 1 PFIZER INC. $75.00 09/18/2019 Non-covered Recipient Entity
COVIGILANT RESEARCH LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 671676577
Principal investigator 1 PFIZER INC. $1,207.99 09/11/2019 Non-covered Recipient Entity
COVIGILANT RESEARCH LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 671675783
Principal investigator 1 Amgen Inc. $67.86 09/10/2019 Non-covered Recipient Entity
CARDIOLOGY SPECIALISTS MEDICAL GROUP
GALACTIC-HF No dispute reported 06/30/2026 675783827
Principal investigator 1 Boehringer Ingelheim International GmbH $1,129.00 09/10/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703919013
Principal investigator 1 Boehringer Ingelheim International GmbH $1,129.00 09/10/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703919015
Principal investigator 1 Boehringer Ingelheim International GmbH $1,048.00 09/10/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703919017
Principal investigator 1 Boehringer Ingelheim International GmbH $1,535.00 09/06/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703918945
Principal investigator 1 Boehringer Ingelheim International GmbH $1,535.00 09/06/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703918947
Principal investigator 1 Boehringer Ingelheim International GmbH $1,379.00 09/06/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703918949
Principal investigator 1 Boehringer Ingelheim International GmbH $0.22 09/04/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703920695
Principal investigator 1 Boehringer Ingelheim International GmbH $25.38 09/04/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703920703
Principal investigator 1 Boehringer Ingelheim International GmbH $40.69 09/04/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703921197
Principal investigator 1 Boehringer Ingelheim International GmbH $40.69 09/04/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703921279
Principal investigator 1 Boehringer Ingelheim International GmbH $30.52 09/04/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703921285
Principal investigator 1 Boehringer Ingelheim International GmbH $46.57 09/04/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703921357
Principal investigator 1 Boehringer Ingelheim International GmbH $40.69 09/04/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703921413
Principal investigator 1 Boehringer Ingelheim International GmbH $40.69 09/04/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703921419
Principal investigator 1 Boehringer Ingelheim International GmbH $40.69 09/04/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703921487
Principal investigator 1 Boehringer Ingelheim International GmbH $30.52 09/04/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703921491
Principal investigator 1 Boehringer Ingelheim International GmbH $50.86 09/04/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703921495
Principal investigator 1 Boehringer Ingelheim International GmbH $4.39 09/04/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703926837
Principal investigator 1 Boehringer Ingelheim International GmbH $40.69 09/04/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703926841
Principal investigator 1 Boehringer Ingelheim International GmbH $51.18 09/04/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703926845
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $4,574.60 08/31/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 704731369
Principal investigator 1 PFIZER INC. $226.94 08/14/2019 Non-covered Recipient Entity
COVIGILANT RESEARCH LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 671669587
Principal investigator 1 Boehringer Ingelheim International GmbH $1,129.00 08/06/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703917501
Principal investigator 1 Boehringer Ingelheim International GmbH $1,048.00 08/01/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703917631
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $1,524.87 07/31/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 704731367
Principal investigator 1 Boehringer Ingelheim International GmbH $1,535.00 07/08/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703914917
Principal investigator 1 Boehringer Ingelheim International GmbH $1,048.00 07/08/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703914919
Principal investigator 1 Boehringer Ingelheim International GmbH $1,048.00 07/08/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703914921
Principal investigator 1 Boehringer Ingelheim International GmbH $1,535.00 07/08/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703914923
Principal investigator 1 Boehringer Ingelheim International GmbH $1,379.00 07/08/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703914925
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $4,066.31 06/30/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 704731365
Principal investigator 1 PFIZER INC. $226.94 06/26/2019 Non-covered Recipient Entity
COVIGILANT RESEARCH LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 671655731
Principal investigator 1 Amgen Inc. $6,815.00 06/25/2019 Non-covered Recipient Entity
COVIGILANT RESEARCH LLC
GALACTIC-HF No dispute reported 06/30/2026 675784845
Principal investigator 1 Boehringer Ingelheim International GmbH $1,535.00 06/12/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703912827
Principal investigator 1 Boehringer Ingelheim International GmbH $1,535.00 06/12/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703912829
Principal investigator 1 Boehringer Ingelheim International GmbH $1,535.00 06/12/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703912831
Principal investigator 1 Boehringer Ingelheim International GmbH $1,535.00 06/12/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703912833
Principal investigator 1 Boehringer Ingelheim International GmbH $1,379.00 06/12/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703912835
Principal investigator 1 Boehringer Ingelheim International GmbH $1,379.00 06/12/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703912837
Principal investigator 1 Boehringer Ingelheim International GmbH $1,048.00 06/12/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703912863
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $4,066.31 05/31/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 704731363
Principal investigator 1 PFIZER INC. $1,565.28 05/29/2019 Non-covered Recipient Entity
COVIGILANT RESEARCH LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 671656039
Principal investigator 1 PFIZER INC. $4,300.15 05/22/2019 Non-covered Recipient Entity
COVIGILANT RESEARCH LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 671656115
Principal investigator 1 Boehringer Ingelheim International GmbH $1,535.00 05/17/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703911723
Principal investigator 1 Boehringer Ingelheim International GmbH $1,379.00 05/17/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703912025
Principal investigator 1 Boehringer Ingelheim International GmbH $1,535.00 05/17/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703912243
Principal investigator 1 PFIZER INC. $10,198.35 05/15/2019 Non-covered Recipient Entity
COVIGILANT RESEARCH LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 671656443
Principal investigator 1 Boehringer Ingelheim International GmbH $1,379.00 05/02/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703911353
Principal investigator 1 Boehringer Ingelheim International GmbH $1,535.00 05/02/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703911637
Principal investigator 1 Boehringer Ingelheim International GmbH $1,535.00 05/02/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703911879
Principal investigator 1 Boehringer Ingelheim International GmbH $51.98 05/01/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703914197
Principal investigator 1 Boehringer Ingelheim International GmbH $51.98 05/01/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703914199
Principal investigator 1 Boehringer Ingelheim International GmbH $51.98 05/01/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703914203
Principal investigator 1 Boehringer Ingelheim International GmbH $51.98 05/01/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703914205
Principal investigator 1 Boehringer Ingelheim International GmbH $51.98 05/01/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703914207
Principal investigator 1 Boehringer Ingelheim International GmbH $51.98 05/01/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703914211
Principal investigator 1 Boehringer Ingelheim International GmbH $51.98 05/01/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703914213
Principal investigator 1 Boehringer Ingelheim International GmbH $51.98 05/01/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703914289
Principal investigator 1 Boehringer Ingelheim International GmbH $197.57 05/01/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703914491
Principal investigator 1 Boehringer Ingelheim International GmbH $5.10 05/01/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703914499
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $3,558.02 04/30/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 704731349
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $3,558.02 04/30/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 704731351
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $3,558.02 04/30/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 704731353
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $3,558.02 04/30/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 704731355
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $3,558.02 04/30/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 704731357
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $3,558.02 04/30/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 704731359
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $3,558.02 04/30/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 704731361
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $3,558.02 04/30/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 704731389
Principal investigator 1 Boehringer Ingelheim International GmbH $103.88 04/02/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703913659
Principal investigator 1 Boehringer Ingelheim International GmbH $103.88 04/02/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703913765
Principal investigator 1 Boehringer Ingelheim International GmbH $54.17 03/04/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703909447
Principal investigator 1 Boehringer Ingelheim International GmbH $2,750.00 02/04/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703905007
Principal investigator 1 Boehringer Ingelheim International GmbH $1,273.00 02/04/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703906227
Principal investigator 1 Boehringer Ingelheim International GmbH $113.74 02/01/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703908071
Principal investigator 1 Boehringer Ingelheim International GmbH $215.24 02/01/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703908073
Principal investigator 1 Boehringer Ingelheim International GmbH $53.06 02/01/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703908075
Principal investigator 1 Boehringer Ingelheim International GmbH $53.06 02/01/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703908077
Principal investigator 1 Boehringer Ingelheim International GmbH $11.45 02/01/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703908079
Principal investigator 1 Boehringer Ingelheim International GmbH $74.28 02/01/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703908081
Principal investigator 1 Boehringer Ingelheim International GmbH $48.58 02/01/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703908083
Principal investigator 1 Boehringer Ingelheim International GmbH $50.42 02/01/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703908157
Principal investigator 1 Boehringer Ingelheim International GmbH $84.90 02/01/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703908159
Principal investigator 1 Boehringer Ingelheim International GmbH $93.44 02/01/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703908161
Principal investigator 1 Boehringer Ingelheim International GmbH $74.28 02/01/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703908163
Principal investigator 1 Boehringer Ingelheim International GmbH $63.67 02/01/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703908165
Principal investigator 1 Boehringer Ingelheim International GmbH $53.06 02/01/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703908167
Principal investigator 1 Boehringer Ingelheim International GmbH $63.67 02/01/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703908169
Principal investigator 1 Boehringer Ingelheim International GmbH $52.96 02/01/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703908171
Principal investigator 1 Boehringer Ingelheim International GmbH $74.28 02/01/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703908173
Principal investigator 1 Boehringer Ingelheim International GmbH $25.10 02/01/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703908175
Principal investigator 1 Boehringer Ingelheim International GmbH $138.37 02/01/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703909341
Principal investigator 1 Boehringer Ingelheim International GmbH $56.87 02/01/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703909343
Principal investigator 1 Boehringer Ingelheim International GmbH $10.61 02/01/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703909345
Principal investigator 1 Boehringer Ingelheim International GmbH $54.45 02/01/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703909347
Principal investigator 1 Boehringer Ingelheim International GmbH $31.84 02/01/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703909349
Principal investigator 1 Boehringer Ingelheim International GmbH $26.48 02/01/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703909425
Principal investigator 1 Boehringer Ingelheim International GmbH $21.22 02/01/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703909427
Principal investigator 1 Boehringer Ingelheim International GmbH $53.06 02/01/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703909429
Principal investigator 1 Boehringer Ingelheim International GmbH $63.67 02/01/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703909431
Principal investigator 1 Boehringer Ingelheim International GmbH $5.72 02/01/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703909433
Principal investigator 1 Boehringer Ingelheim International GmbH $21.22 02/01/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703909435
Principal investigator 1 Boehringer Ingelheim International GmbH $21.22 02/01/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703909437
Principal investigator 1 Boehringer Ingelheim International GmbH $21.22 02/01/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703909439
Principal investigator 1 Boehringer Ingelheim International GmbH $25.10 02/01/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703909441
Principal investigator 1 Boehringer Ingelheim International GmbH $40.04 02/01/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703909443
Principal investigator 1 Boehringer Ingelheim International GmbH $31.84 02/01/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703909445
Principal investigator 1 Boehringer Ingelheim International GmbH $63.67 02/01/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703926041
Principal investigator 1 Boehringer Ingelheim International GmbH $50.42 02/01/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703926251
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $2,541.44 01/31/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 704731385
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $2,541.44 01/31/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 704731387
Principal investigator 1 Amgen Inc. $6,944.78 01/28/2019 Non-covered Recipient Entity
COVIGILANT RESEARCH, LLC
GALACTIC-HF No dispute reported 06/30/2026 675784849
Principal investigator 1 Boehringer Ingelheim International GmbH $1,273.00 01/22/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703905093
Principal investigator 1 Boehringer Ingelheim International GmbH $2,750.00 01/22/2019 Non-covered Recipient Entity
COVIGILANT RSRCH LLC
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703905101
Principal investigator 1 Amgen Inc. $77.25 01/01/2019 Non-covered Recipient Entity
COVIGILANT RESEARCH LLC
GALACTIC-HF No dispute reported 06/30/2026 675784847